University of Washington
Nov 20, 2024
Additional Partnerships
Researchers at Tempus partnered with the University of Washington to study the genomic alteration (GA) landscape of pure urothelial (UC) and histologic subtypes of bladder cancer.
This analysis promises to yield insight into variant histology bladder cancers to better understand their lack of clinical response, and potentially identify modes of therapeutic intervention.
This study was presented at the ASCO GU Cancers Symposium in 2024.
Related content